Fax: (212) 410–7194
Original Article
You have full text access to this OnlineOpen article
Phase 1 study of concurrent sunitinib and image-guided radiotherapy followed by maintenance sunitinib for patients with oligometastases
Acute toxicity and preliminary response
Article first published online: 17 JUN 2009
DOI: 10.1002/cncr.24412
Copyright © 2009 American Cancer Society
Additional Information
How to Cite
Kao, J., Packer, S., Vu, H. L., Schwartz, M. E., Sung, M. W., Stock, R. G., Lo, Y.-C., Huang, D., Chen, S.-H. and Cesaretti, J. A. (2009), Phase 1 study of concurrent sunitinib and image-guided radiotherapy followed by maintenance sunitinib for patients with oligometastases. Cancer, 115: 3571–3580. doi: 10.1002/cncr.24412
Publication History
- Issue published online: 20 JUL 2009
- Article first published online: 17 JUN 2009
- Manuscript Accepted: 13 JAN 2009
- Manuscript Revised: 22 DEC 2008
- Manuscript Received: 29 OCT 2008
Funded by
- Mount Sinai School of Medicine
- Department of Radiation Oncology and Pfizer
Corrected by:
Vol. 117, Issue 12, 2826, Article first published online: 14 DEC 2010
- Abstract
- Article
- References
- Cited By
Cited in:
- CrossRef
This article has been cited by:
- 1, , , , , , , , , , , , , , Distant metastases from head and neck squamous cell carcinoma. Part III. Treatment, Oral Oncology, 2012,
- 2, , , , , , Multicenter Prospective Trial of Hypofractionated Radiation Treatment, Toceranib, and Prednisone for Measurable Canine Mast Cell Tumors, Journal of Veterinary Internal Medicine, 2012, 26, 1Direct Link:
- 3, , , Recognizing and reversing the immunosuppressive tumor microenvironment of head and neck cancer, Immunologic Research, 2012,
- 4, , , , , , , , , , , , , , , Stereotactic body radiotherapy for multisite extracranial oligometastases, Cancer, 2012, 118, 11Direct Link:
- 5, , , , , , , Sunitinib targets PDGF-receptor and Flt3 and reduces survival and migration of human meningioma cells, European Journal of Cancer, 2012,
- 6, , , , Targeted agents in non-small cell lung cancer (NSCLC): Clinical developments and rationale for the combination with thoracic radiotherapy, Cancer Treatment Reviews, 2012, 38, 6, 626
- 7, , Updates on the Management of Gastrointestinal Stromal Tumors, Surgical Oncology Clinics of North America, 2012, 21, 2, 301
- 8, , , , , , , , , , , A phase 1b trial of the combination of the antiangiogenic agent sunitinib and radiation therapy for patients with primary and metastatic central nervous system malignancies, Cancer, 2011, 117, 24Direct Link:
- 9, , , , , , Comparison of outcomes in patients with stage III versus limited stage IV non-small cell lung cancer, Radiation Oncology, 2011, 6, 1, 80
- 10, , , , , Current state of knowledge regarding the use of antiangiogenic agents with radiation therapy, Cancer Treatment Reviews, 2011,
- 11, , , , Oligometastases Treated With Stereotactic Body Radiotherapy: Long-Term Follow-Up of Prospective Study, International Journal of Radiation Oncology*Biology*Physics, 2011,
- 12, , , , , Radiobiological rationale and clinical implications of hypofractionated radiation therapy, Cancer/Radiothérapie, 2011, 15, 3, 221
- 13, , , , , , Targeting immune suppressing myeloid-derived suppressor cells in oncology, Critical Reviews in Oncology/Hematology, 2011, 77, 1, 12
- 14, , , , , , , , , , , , The Effect of Sunitinib on Immune Subsets in Metastatic Clear Cell Renal Cancer, Urologia Internationalis, 2011, 86, 1, 53
- 15, , Emerging Role of Radiotherapy in the Management of Liver Metastases, The Cancer Journal, 2010, 16, 2, 150
- 16, , , , , Head and Neck Squamous Cell Carcinoma: New Translational Therapies, Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine, 2010, 77, 6Direct Link:
- 17, , Radiotherapy in combination with vascular-targeted therapies, Radiology and Oncology, 2010, 44, 2, 67

1097-0142/asset/olbannerleft.gif?v=1&s=ca681f5719430b26e1bc15e9ea4c9fc0a7110104)
1097-0142/asset/olbannerright.gif?v=1&s=8142566facf7e76aef9be6c51162a2e920b3b9f9)
1097-0142/asset/cover.gif?v=1&s=a7299bc18f075294c232ade468773cd0672bd470)